Type I regulatory T cells in autoimmunity and inflammatory diseases

International Archives of Allergy and Immunology

Volumn 140, Issue 2, 2006, Pages 174-183

  Veldman, Christian ^a   Nagel, Angela ^a   Hertl, Michael ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Autoimmunity; Inflammatory diseases; Multiple sclerosis; Regulatory T cells; Transcription factor

Indexed keywords

INTERLEUKIN 10; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA ANTIBODY;

ADOPTIVE IMMUNOTHERAPY; ALLERGY; ANIMAL CELL; AUTOIMMUNE DISEASE; CANCER; CD4+ CD25+ T LYMPHOCYTE; CELL ISOLATION; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOLOGY; INFECTION; INFLAMMATION; LYMPHOCYTE ACTIVATION; MULTIPLE SCLEROSIS; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE SUBPOPULATION; TH3 CELL; THYMUS; TRANSCRIPTION REGULATION; TYPE 1 REGULATORY T LYMPHOCYTE;

AUTOIMMUNITY; COMMUNICABLE DISEASES; HUMANS; HYPERSENSITIVITY; NEOPLASMS; T-LYMPHOCYTES, REGULATORY;

EID: 33646394713     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000092576     Document Type: Review

References (89)

1. Roncarolo MG, Levings MK: The role of different subsets of T regulatory cells in controlling autoimmunity. Curr Opinion Immunol 2000;12:676-683.
2. Gershon RK: A disquisition on suppressor T cells. Transplant Rev 1975;26:170-185.
3. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M: Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995; 155:1151-1164.
4. Sakaguchi S, Sakaguchi N, Shimizu J, Yamazaki S, Sakihama T, Itoh M, Kuniyasu Y, Nomura T, Toda M, Takahashi T: Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev 2001;182: 18-32.
5. + T helper cells. J Exp Med 2002;196:255-261.
6. + regulatory, contact-dependent T cells induce interleukin 10-producing, contact-independent type 1-like regulatory T cells. J Exp Med 2002; 196:247-254.
7. Wood KJ, Sakaguchi S: Regulatory T cells in transplantation tolerance. Nat Rev Immunol 2003;3:199-210.
8. Shevach EM: Regulatory T cells in autoimmmunity. Annu Rev Immunol 2000;18:423-449.
9. Seddon B, Mason D: The third function of the thymus. Immunol Today 2000;21:95-99.
10. Su L, Creusot RJ, Gallo EM, Chan SM, Utz PJ, Fathman CG, Ermann J: MurineCD4+CD25+ regulatory T cells fail to undergo chromatin remodeling across the proximal promoter region of the IL-2 gene. J Immunol 2004;173:4994-5001.
11. Levings MK, Sangregorio R, Galbiati F, Squadrone S, de Waal Malefyt R, Roncarolo MG: IFN-alpha and IL-10 induce the differentiation of human type 1 T regulatory cells. J Immunol 2001;166:5530-5539.
12. + T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J Immunol 1998;160:1212-1218.
13. Takahashi T, Tagami T, Yamazaki S, Uede T, Shimizu J, Sakaguchi N, Mak TW, Sakaguchi S: Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med 2000;192:303-310.
14. + regulatory cells that control intestinal inflammation. J Exp Med 2000;192:295-230.
15. Huang CT, Workman CJ, Flies D, Pan X, Marson AL, Zhou G, Hipkiss EL, Ravi S, Kowalski J, Levitsky HI, Powell JD, Pardoll DM, Drake CG, Vignali DA: Role of LAG-3 in regulatory T cells. Immunity 2004;21:503-513.
16. Fukaura H, Kent SC, Pietrusewicz MJ, Khoury SJ, Weiner HL, Hafler DA: Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients. J Clin Invest 1996;98:70-77.
17. Chen Y, Kuchroo VK, Inobe J, Hafler DA, Weiner HL: Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 1994;265:1237-1240.
18. Teitelbaum D, Arnon R, Sela M: Immunomodulation of experimental autoimmune encephalomyelitis by oral administration of copolymer 1. Proc Natl Acad Sci USA 1999;96:3842-3847.
19. Groux H, O'Garra A, Bigler M, Rouleau M, Antonenko S, de Vries JE, Roncarolo MG: A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997;389:737-742.
20. Bacchetta R, Sartirana C, Levings MK, Bordignon C, Narula S, Roncarolo MG: Growth and expansion of human T regulatory type 1 cells are independent from TCR activation but require exogenous cytokines. Eur J Immunol 2002;32:2237-2245.
21. Cong Y, Weaver CT, Lazenby A, Elson CO: Bacterial-reactive T regulatory cells inhibit pathogenic immune responses to the enteric flora. J Immunol 2002;169:6112-6122.
22. McGuirk P, McCann C, Mills KH: Pathogenspecific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis. J Exp Med 2002;195:221-228.
23. Cottrez F, Hurst SD, Coffman RL, Groux H: T regulatory cells 1 inhibit a Th2-specific response in vivo. J Immunol 2000;165:4848-4853.
24. Veldman CM, Gebhard K, Uter W, Wassmuth R, Goetzinger J, Hertl M: T cell recognition of desmoglein 3 peptides in patients with pemphigus vulgaris and healthy individuals. J Immunol 2004;172:3883-3892.
25. + T cells with regulatory properties by repetitive stimulation with allogenic immature human dendritic cells. J Exp Med 2000;192:1213-1222.
26. + T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J Exp Med 2002;195:603-616.
27. Levings MK, Gregori S, Tresoldi E, Cazzaniga S, Bonini C, Roncarolo MG: Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25+CD4+ Tr cells. Blood 2005;105:1162-1169.
28. Qin S, Cobbold SP, Pope H, Elliott J, Kioussis D, Davies J, Waldmann H: 'Infectious' transplantation tolerance. Science 1993;259:974-978.
29. Modigliani Y, Bandiera A, Coutinho A: A model for developmentally acquired thymus-dependent tolerance to central and peripheral antigens. Immunol Rev 1996;149:155-165.
30. Cobbold S, Waldmann H: Infectious tolerance. Curr Opin Immunol 1998;10:518-528.
31. Stassen M, Fondel S, Bopp T, Richter C, Muller C, Kubach J, Becker C, Knop J, Enk AH, Schmitt S, Schmitt E, Jonuleit H: Human CD25+ regulatory T cells: two subsets defined by the integrins alpha 4 beta 7 or alpha 4 beta 1 confer distinct suppressive properties upon CD4+ T helper cells. Eur J Immunol 2004;34:1303-1311.
32. Foussat A, Cottrez F, Brun V, Founier N, Breittmayer JP, Groux H: A comparative study between T regulatory type 1 and CD4+CD25+ T cells in the control of inflammation. J Immunol 2003;171:5018-5026.
33. + regulatory T cells and IL-10. J Immunol 2003;171:971-978.
34. Bacchetta R, Bigler M, Touraine JL, Parkman R, Tovo PA, Abrams J, de Waal Malefyt R, de Vries JE, Roncarolo MG: High levels of interleukin-10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells. J Exp Med 1994;179:493-502.
35. Holler E, Roncarolo MG, Hintermeier-Knabe R, Eissner G, Ertl B, Schulz U, Knabe H, Kolb HJ, Andreesen R, Wilmanns W: Prognostic significance of increased IL-10 production in patients prior to allogeneic bone marrow transplantation. Bone Marrow Transplant 2000;25: 237-241.
36. Van Buskirk AM, Burlingham WJ, Jankowska-Gan E, Chin T, Kusaka S, Geissler F, Pelletier RP, Orosz CG: Human allograft acceptance is associated with immune regulation. J Clin Invest 2000;106:145-155.
37. Khoo UY, Proctor IE, Macpherson AJ: CD4 T cell down-regulation in human intestinal mucosa: evidence for intestinal tolerance to luminal bacterial antigens. J Immunol 1997;158:3626-3634.
38. Kitani A, Chua K, Nakamura K, Strober W: Activated self-MHC-reactive T cells have the cytokine phenotype of Th3/T regulatory cell 1 T cells. J Immunol 2000;165:691-702.
39. + T cell subset is related to Th1/Th2 balance and disease severity in rheumatoid arthritis. Arthritis Rheum 2000;43:617-627.
40. Huizinga TW, van der Linden MW, Deneys-Laporte V, Breedveld FC: Interleukin-10 as an explanation for pregnancy-induced flare in systemic lupus erythematosus and remission in rheumatoid arthritis. Rheumatology 1999;38: 496-498.
41. Wildbaum G, Netzer N, Karin N: Tr1 cell dependent active tolerance blunts the pathogenic effects of determinant spreading. J Clin Invest 2002;110:701-710.
42. Chen C, Lee WH, Yun P, Snow P, Liu CP: Induction of autoantigen-specific Th2 and Tr1 regulatory T cells and modulation of autoimmune diabetes. J Immunol 2003;171:733-738.
43. Arif S, Tree TI, Astill TP, Tremble JM, Bishop AJ, Dayan CM, Roep BO, Peakman M: Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health. J Clin Invest 2004;113: 451-458.
44. Hertl M, Veldman C. Pemphigus - paradigm of autoantibody-mediated autoimmunity. Skin Pharmacol Appl Skin Physiol 2001;14: 408-418.
45. Veldman C, Höhne A, Dieckmann D, Schuler G, Hertl M: Type I regulatory T cells specific for desmoglein 3 are more frequently detected in healthy individuals than in patients with pemphigus vulgaris. J Immunol 2004;172: 6468-6475.
46. Veldman CM, Pahl A, Beissert S, Hansen W, Buer J, Dieckmann D, Schuler G, Hertl M: Inhibition of the transcription factor Foxp3 converts desmoglein 3-specific type 1 regulatory T cells into T helper 2-like cells. J Immunol, in press.
47. Akdis CA, Blesken T, Akdis M, Wuthrich B, Blaser K: Role of interleukin 10 in specific immunotherapy. J Clin Invest 1998;102:98-106.
48. Nouri-Aria KT, Wachholz PA, Francis JN, Jacobson MR, Walker SM, Wilcock LK, Staple SQ, Aalberse RC, Till SJ, Durham SR: Grass pollen immunotherapy induces mucosal and peripheral IL-10 responses and blocking IgG activity. J Immunol 2004;172:3252-3259.
49. Cavani A, Nasorri F, Prezzi C, Sebastiani S, Albanesi C, Girolomoni G: Human CD4 T lymphocytes with remarkable regulatory functions on dendritic cells and nickel-specific Th1 immune responses. J Invest Dermatol 2000;114:295-302.
50. Rustemeyer T, von Blomberg BM, van Hoogstraten IM, Bruynzeel DP, Scheper RJ: Analysis of effector and regulatory immune reactivity to nickel. Clin Exp Allergy 2004;34:1458-1466.
51. Akdis M, Verhagen J, Taylor A, Karamloo F, Karagiannidis C, Crameri R, Thunberg S, Deniz G, Valenta R, Fiebig H, Kegel C, Disch R, Schmidt-Weber CB, Blaser K, Akdis CA: Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J Exp Med 2004;199:1567-1575.
52. Akbari O, DeKruyff RH, Umetsu DT: Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat Immunol 2001;2:725-731.
53. Akbari O, Freeman GJ, Meyer EH, Greenfield EA, Chang TT, Sharpe AH, Berry G, DeKruyff RH, Umetsu DT: Antigen-specific regulatory T cells develop via the ICOS- ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity. Nat Med 2002;8:1024-1032.
54. Correale J, Gilmore W, McMillan M, Li S, McCarthy K, Le T, Weiner LP: Patterns of cytokine secretion by autoreactive proteolipid protein-specific T cell clones during the course of multiple sclerosis. J Immunol 1995;154:2959-2968.
55. Boussiotis VA, Tsai EY, Yunis EJ, Thim S, Delgado JC, Dascher CC, Berezovskaya A, Rousset D, Reynes JM, Goldfeld AE: IL-10-producing T cells suppress immune responses in tuberculosis patients. J Clin Invest 2000; 105:1317-1325.
56. Plebanski M, Flanagan KL, Lee EA, Reece WH, Hart K, Gelder C, Gillespie G, Pinder M, Hill AV: Interleukin 10-mediated immunosuppression by a variant CD4 T cell epitope of Plasmodium falciparum. Immunity 1999;10:651-660.
57. Pohl-Koppe A, Balashov KE, Steere AC, Logigian EL, Hafler DA: Identification of a T cell subset capable of both IFN-γ and IL-10 secretion in patients with chronic Borrelia burgdorferi infection. J Immunol 1998;160:1804-1810.
58. h2 shift. Int Immunol 2000;12:623-630.
59. Roncarolo MG, Levings MK, Traversari C: Differentiation of T regulatory cells by immature dendritic cells. J Exp Med 2001;193:F5-F10.
60. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A: Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001;19: 683-765.
61. Brady MT, Mac Donald AJ, Rowan AC, Mills KHG: Hepatitis C virus non-structural protein 4 suppress Th1 responses by stimulating IL-10 production from monocytes. Eur J Immunol 2003;33:3448-3457.
62. Lavelle EC, McNeela E, Armstrong ME, Leavy O, Higgins SC, Mills KH: Cholera toxin promotes the induction of regulatory T cells specific for bystander antigens by modulating dendritic cell activation. J Immunol 2003;171: 2384-2392.
63. Ross PJ, Lavelle EC, Mills KHG, Boyd AP: Adenylate cyclase toxin from Bordetella pertussis synergises with lipopolysaccaride to promote innate IL-10 production and enhance the inductin of Th2 and regulatory T cells. Infect Immun 2004;72:1568-1579.
64. + T cells responding to antigen presentation by melanoma cells. Melanoma Res 1999;9:173-180.
65. + T cell response to repetitive stimulation with antigen-presenting cells in vitro: implications in designing antigen-presenting cell-based tumor vaccines. J Immunol 1999; 162:5576-5583.
66. Liyanage UK, Moore TT, Joo HG, Tanaka Y, Herrmann V, Doherty G, Drebin JA, Strasberg SM, Eberlein TJ, Goedegebuure PS, Linehan DC: Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. J Immunol 2002;169: 2756-2761.
67. Gray CP, Arosio P, Hersey P: Heavy chain ferritin activates regulatory T cells by induction of changes in dendritic cells. Blood 2002;99: 3326-3334.
68. + T-regulatory cells and systemic collapse of antitumour immunity. Immunology 2001;103:449-457.
69. Vicari AP, Chiodoni C, Vaure C, Ait-Yahia S, Dercamp C, Matsos F, Reynard O, Taverne C, Merle P, Colombo MP, O'Garra A, Trinchieri G, Caux C: Reversal of tumor-induced dendritic cell paralysis by CpG immunostimulatory oligonucleotide and anti-interleukin 10 receptor antibody. J Exp Med 2002;196:541-549.
70. Enk AH, Jonuleit H, Saloga J, Knop J: Dendritic cells as mediators of tumor-induced tolerance in metastatic melanoma. Int J Cancer 1997;73:309-316.
71. high regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells. J Immunol 2004;173:1444-1453.
72. Kemper C, Chan AC, Green JM, Brett KA, Murphy KM, Atkinson JP: Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature 2003;421:388-392.
73. Homann D, Holz A, Bot A, Coon B, Wolfe T, Petersen J, Dyrberg TP, Grusby MJ, von Herrath MG: Autoreactive CD4+ T cells protect from autoimmune diabetes via bystander suppression using the IL-4/Stat6 pathway. Immunity 1999;11:463-472.
74. Weiner HL, Mackin GA, Matsui M, Orav EJ, Khoury SJ, Dawson DM, Hafler DA: Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis. Science 1993; 259:1321-1324.
75. Van Regenmortel MH, Guichard G, Benkirane N, Briand JP, Muller S, Brown F: The potential of retro-inverso peptides as synthetic vaccines. Dev Biol Stand 1998;92:139-143.
76. + regulatory T-cells induced by oral insulin treatment protect from type 1 diabetes by blocking the cytokine secretion and pancreatic infiltration of diabetogenic effector T-cells. Diabetes 1999;48:1720-1729.
77. Steinman RM, Nussenzweig MC: Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc Natl Acad Sci USA 2002;99:351-358.
78. + regulatory T cells in vivo in humans. Blood 2002;100:174-177.
79. Brunkow ME, Jeffery EW, Hjerrild KA, Paeper B, Clark LB, Yasayko SA, Wilkinson JE, Galas D, Ziegler SF, Ramsdell F: Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet 2001;27:68-73.
80. Wildin RS, Ramsdell F, Peake J, Faravelli F, Casanova JL, Buist N, Levy-Lahad E, Mazzella M, Goulet O, Perroni L: X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 2001;27:18-20.
81. Hori S, Nomura T, Sakaguchi S: Control of regulatory T cell development by the transcription factor Foxp3. Science 2003;299:1057-1061.
82. + T regulatory cells. Nat Immunol 2003;4:337-342.
83. + regulatory T cells. Nat Immunol 2003;4:330-336.
84. Tivol E, Borriello F, Schweitzer A, Lynch W, Bluestone J, Sharpe A: Loss of CTLA4 leads to massive lymphoproliferation and fatal multi-organ tissue destruction. Immunity 1995;3: 541-547.
85. Waterhouse P, Penninger J, Timms E, Wakeham A, Shahinian A, Lee K, Thompson C, Griesser H, Mak T: Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4. Science 1995;270:985-988.
86. Kulkarni AB, Huh CH, Becker D, Gerser A, Lyght M, Flanders KC, Roberts AB, Sporn MB, Ward JM, Karlsson S: Transforming growth factor-β null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci USA 1993;90:770-774.
87. Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, Yin M, Allen R, Sidman C, Proetzel G, Calvin D : Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature 1992;359:693-699.
88. Khattri R, Kasprowicz D, Cox T, Mortrud M, Appleby MW, Brunkow ME, Ziegler SF, Ramsdell F: The amount of scurfin protein determines peripheral T cell number and responsiveness. J Immunol 2001;167:6312-6320.
89. Loser K, Hansen W, Apelt J, Balkow S, Buer J, Beissert S: In vitro-generated regulatory T cells induced by Foxp3-retrovirus infection control murine contact allergy and systemic autoimmunity. Gene Ther 2005;12:1294-1304.